Lockdown Support

WHY THE FAUCI EMAILS MATTER

Formed by ordinary citizens at the start of the COVID-19 outbreak, PANDA’s founders believed that decision-makers could be persuaded by proper research. We underestimated the extent to which freedom of speech is under attack today.

Read More »
Bret Weinstein

Biologist Declares that EUA’s at Risk

There’s a suggestion put now on Right’s mainstream media that the U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) would automatically be repealed by law if the drug used to fight parasite-borne disease, ivermectin, were proven to be effective and safe.

Read More »
Ivermectin Research

Emerging Evidence Demonstrating the Efficacy of Ivermectin

After COVID-19 emerged on U.S shores, providers began reviewing the emerging basic science, translational, and clinical data to identify potentially effective treatment options. In addition, a multitude of both novel and repurposed therapeutic agents were used empirically and studied within clinical trials.

Read More »
Beware all assets

Beware all assets!

With the ANC having declared itself in favour of a provision for the custodianship of ‘certain’ land as part of its preferred formulation for the constitutional amendment, it is important not to lose sight of a critical fundamental: land may be the immediate target of these measures, but it will not be the only one.

Read More »
Confronting the real ‘power hierarchy’ barring SA’s upward mobility

The real ‘power hierarchy’ barring SA’s upward mobility

In his snide critique of the IRR and other opponents of the Promotion of Equality and Prevention of Unfair Discrimination (Pepuda) Amendment Bill (the Bill), Professor Pierre de Vos of the University of Cape Town Law Faculty indicates that all inequalities in South Africa are the result of ‘structural or systemic barriers’ resulting from the ‘power hierarchy’.

Read More »
Polycythemia

Polycythemia and Covid-19

Polycythemia means too many cells and the primary risk is blood clotting, which is lethal to 1 in 4 people globally & annually affects 900 000 people in the US.

Read More »

Join our
Mailing List

* indicates required
/ ( mm / dd )